Aurion Biotech

Aurion Biotech

WA - Seattle
Biotechnology4 H-1B visas (FY2023)

Focus: Ocular Transplant Therapies

Aurion Biotech is a life sciences company focused on Ocular Transplant Therapies.

Ophthalmology
Funding Stage
PUBLIC
Open Jobs
11

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT05309135A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction
Phase 1
Phase 1/2
Clinical Trials (1)
NCT06041256A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)
Phase 1/2
Cryopreserved AURN001
Corneal Edema
Phase 2
Clinical Trials (1)
NCT06630169Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Phase 2
Combination Product: AURN001 + Y-27632
Corneal Edema
Phase 3
Clinical Trials (1)
NCT07368959AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Phase 3

Open Jobs (11)

Interview Prep Quick Facts
Founded: 2015
Portfolio: 4 clinical trials
Top TAs: Ophthalmology
H-1B (2023): 4 approvals
Open Roles: 11 active jobs
Therapeutic Area Focus
Ophthalmology
4 pipeline
Marketed
Pipeline

Hiring Trend

Stable
11
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
4
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub